SCYNEXIS, Inc. reported the following changes to its executive leadership team: Dr. Taglietti, after more than seven years leading the company, announced plans to retire at the end of the year 2022. He will leave his position as company's President and Chief Executive Officer and will step down from the Board of Directors on December 31, 2022. David Angulo, M.D., who has served as Chief Medical Officer for the past seven years, will become President and Chief Executive Officer of the company and join the Board of Directors, effective January 1, 2023.